- Open Access
Correction to: Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients
© The Author(s) 2019
- Received: 9 January 2019
- Accepted: 9 January 2019
- Published: 14 January 2019
The original article was published in Cancer Cell International 2018 18:215
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Cao X-x, Cai H, Mao Y-y, Wu Q. Zhang Lu, Zhou D-b, Jian L. Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients. Cancer Cell Int. 2018;18:215. https://doi.org/10.1186/s12935-018-0716-7.View ArticlePubMedPubMed CentralGoogle Scholar